鉴定预测晚期卵巢癌化疗后无进展生存期的种系变异-猫眼课题宝

鉴定预测晚期卵巢癌化疗后无进展生存期的种系变异

批准号：

nhmrc : 1051698

负责人：

A/Pr Juliet French

金额：

$42.22万

依托单位：

Queensland Institute of Medical Research

依托单位国家：

澳大利亚

项目类别：

Project Grants

财政年份：

2013

资助国家：

澳大利亚

项目状态：

已结题

起止时间：

2013-01-01 至 2015-12-31

来源：

https://researchdata.edu.au/identification-germline-variation-ovarian-cancer/112232

关键词：

Identification germline variation predicts progression

项目摘要

项目成果

A/Pr Juliet French的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

Women diagnosed with ovarian cancer typically undergo surgery, followed by chemotherapy. However, the efficacy of chemotherapy varies widely, with some women responding well, whilst others are exposed to the toxic effects of a treatment that does them little good. We aim to identify the genes which explain why there are differences in response. This will lead to more individualised chemotherapy and improved outcomes for women with ovarian cancer.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文